Patents by Inventor Ana GARZÓN GUTIÉRREZ

Ana GARZÓN GUTIÉRREZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190365615
    Abstract: Present invention refers to tooth re-mineralization materials incorporating calcium phosphates and calcium-free silicon compounds. Materials are efficacious in re-mineralization of teeth and occlusion of exposed dentinal tubules either when used alone or in dentifrice preparations for oral healthcare. Preferred calcium phosphates include anhydrous dicalcium phosphate, dicalcium phosphate dihydrate, hydroxyapatite and amorphous calcium phosphate that can incorporate partial substitutions of calcium by divalent metallic ions such as Mg++, Zn++, Ba++, Fe++, Sn++ and Sr++. Preferred calcium-free silicon compounds include silicon oxide, silica gel, methasilicic acid, orthosilicic acid, silicic acid, and combinations thereof.
    Type: Application
    Filed: June 19, 2017
    Publication date: December 5, 2019
    Inventors: Arcadio GARCÍA DE CASTRO ANDREWS, Raúl GARCÍA CARRODEGUAS, Sussette PADILLA MONDEJAR, Ana GARZÓN GUTIÉRREZ, Manuel TOLEDANO PÉREZ, Raquel OSORIO RUIZ
  • Patent number: 8951534
    Abstract: The invention relates to therapeutic vaccines for the treatment of neoplasias caused by the human papillomavirus (HPV). In particular, the vaccines of the present invention are formed by chimeric virus-like capsids of birnavirus containing papillomavirus antigens.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: February 10, 2015
    Assignee: Chimera Pharma, S.L.U
    Inventors: Thomas Zurcher, Cayetano Von Kobbe, Juan J. Bernal, Ignacio Jiménez Torres, Gloria Calderita Lucas, Margarita Rodriguez Garcia, Ana Garzon Gutierrez, Virginia Gondar Sousa E Silva, Arcadio García De Castro, Irene Pino De La Huerga
  • Publication number: 20120269844
    Abstract: The invention relates to therapeutic vaccines for the treatment of neoplasias caused by the human papillomavirus (HPV). In particular, the vaccines of the present invention are formed by chimeric virus-like capsids of birnavirus containing papillomavirus antigens.
    Type: Application
    Filed: November 5, 2010
    Publication date: October 25, 2012
    Applicant: Chimera Pharma, S.L.U.
    Inventors: Thomas Zurcher, Cayetano Von Kobbe, Juan J. Bernal, Ignacio Jiménez Torres, Gloria Calderita Lucas, Margarita Rodriguez Garcia, Ana Garzon Gutierrez, Virginia Gondar Sousa E Silva, Arcadio Garcia De Castro, Irene Pino De La Huerga